Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in

Qitong Chen1, Dengjie Ouyang1,2, Munawar Anwar1

  • 1Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.

Frontiers in Oncology
|March 22, 2021
PubMed